Form D · Pharmaceuticals
Curevo, Inc.
Bothell, WA · CIK 0001903219
Offering snapshot reported Mar 18, 2025 · SEC filing
- Reported sold
- $42.4M Offering amount: $84.8M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 6, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2025 | Initial | $42,414,174 | No comparison | 11 | SEC filing |
| Nov 21, 2022 | Initial | $22,000,002 | No comparison | 7 | SEC filing |
| Jan 12, 2022 | Initial | $45,583,151 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-541272
Source: Form D, filed Mar 18, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Baeksik Bae | Director |
| Mario Barro | Director |
| Julie Brooks | Executive |
| Jae Uk Jeong | Director |
| Giovanni Mariggi | Director |
| Charles Petty | Director |
| George Simeon | Director, Executive |
| Moncef Slaoui | Director |
| Tal Zaks | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
18911 North Creek Pkwy, Suite 150
Bothell, WA, 98011
Phone: (206) 492-5722
Bothell, WA, 98011
Phone: (206) 492-5722